Mazzini L - Search Results

1

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.

Beghi E, Pupillo E, Bonito V, Buzzi P, Caponnetto C, Chiò A, Corbo M, Giannini F, Inghilleri M, Bella VL, Logroscino G, Lorusso L, Lunetta C, Mazzini L, Messina P, Mora G, Perini M, Quadrelli ML, Silani V, Simone IL, Tremolizzo L; Italian ALS Study Group. Beghi E, et al. Among authors: mazzini l. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):397-405. doi: 10.3109/21678421.2013.764568. Epub 2013 Feb 19. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23421600 Clinical Trial.

2

A follow-up electromyographic investigation of ALS patients treated with high dosage gangliosides.

Pinelli P, Mazzini L, Mora G, Pisano F, Villani A. Pinelli P, et al. Among authors: mazzini l. Adv Exp Med Biol. 1987;209:285-91. doi: 10.1007/978-1-4684-5302-7_41. Adv Exp Med Biol. 1987. PMID: 3577919 No abstract available.

3

An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis.

Mazzini L, Testa D, Balzarini C, Mora G. Mazzini L, et al. J Neurol. 1994 Feb;241(4):223-7. doi: 10.1007/BF00863772. J Neurol. 1994. PMID: 8195821 Clinical Trial.

4

Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis.

Mazzini L, Corrà T, Zaccala M, Mora G, Del Piano M, Galante M. Mazzini L, et al. J Neurol. 1995 Oct;242(10):695-8. doi: 10.1007/BF00866922. J Neurol. 1995. PMID: 8568533

5

Motor neuron disease: usefulness of transcranial magnetic stimulation in improving the diagnosis.

Miscio G, Pisano F, Mora G, Mazzini L. Miscio G, et al. Among authors: mazzini l. Clin Neurophysiol. 1999 May;110(5):975-81. doi: 10.1016/s1388-2457(99)00030-9. Clin Neurophysiol. 1999. PMID: 10400213

6

A randomized controlled trial of recombinant interferon beta-1a in ALS. Italian Amyotrophic Lateral Sclerosis Study Group.

Beghi E, Chiò A, Inghilleri M, Mazzini L, Micheli A, Mora G, Poloni M, Riva R, Serlenga L, Testa D, Tonali P. Beghi E, et al. Among authors: mazzini l. Neurology. 2000 Jan 25;54(2):469-74. doi: 10.1212/wnl.54.2.469. Neurology. 2000. PMID: 10668716 Clinical Trial.

7

Patients with amyotrophic lateral sclerosis and cancer do not differ clinically from patients with sporadic amyotrophic lateral sclerosis.

Vigliani MC, Polo P, Chiò A, Giometto B, Mazzini L, Schiffer D. Vigliani MC, et al. Among authors: mazzini l. J Neurol. 2000 Oct;247(10):778-82. doi: 10.1007/s004150070092. J Neurol. 2000. PMID: 11127533

8

Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results.

Mazzini L, Balzarini C, Colombo R, Mora G, Pastore I, De Ambrogio R, Caligari M. Mazzini L, et al. J Neurol Sci. 2001 Oct 15;191(1-2):139-44. doi: 10.1016/s0022-510x(01)00611-6. J Neurol Sci. 2001. PMID: 11677005 Clinical Trial.

9

Early symptom progression rate is related to ALS outcome: a prospective population-based study.

Chiò A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, Bottacchi E, Mutani R; Piemonte and Valle d'Aosta Register for ALS (PARALS). Chiò A, et al. Among authors: mazzini l. Neurology. 2002 Jul 9;59(1):99-103. doi: 10.1212/wnl.59.1.99. Neurology. 2002. PMID: 12105314

10

Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis.

Beghi E, Balzarini C, Bogliun G, Logroscino G, Manfredi L, Mazzini L, Micheli A, Millul A, Poloni M, Riva R, Salmoiraghi F, Tonini C, Vitelli E; Italian ALS Study Group. Beghi E, et al. Among authors: mazzini l. Neuroepidemiology. 2002 Nov-Dec;21(6):265-70. doi: 10.1159/000065524. Neuroepidemiology. 2002. PMID: 12411728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page